c-Jun N-terminal Kinase-Dependent Endoplasmic Reticulum Stress Pathway is Critically Involved in Arjunic Acid Induced Apoptosis in Non-Small Cell Lung Cancer Cells

Phytotherapy Research : PTR
HyeEun JooSung-Hoon Kim

Abstract

Though arjunic acid, a triterpene isolated from Terminalia arjuna, was known to have antioxidant, antiinflammatory, and cytotoxic effects, its underlying antitumor mechanism still remains unclear so far. Thus, in the present study, the molecular antitumor mechanism of arjunic acid was examined in A549 and H460 non-small cell lung cancer (NSCLC) cells. Arjunic acid exerted cytotoxicity by 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide (MTT) assay and significantly increased sub-G1 population in A549 and H460 cells by cell cycle analysis. Consistently, arjunic acid cleaved poly (ADP-ribose) polymerase (PARP), activated Bax, and phosphorylation of c-Jun N-terminal kinases (JNK), and also attenuated the expression of pro-caspase-3 and Bcl-2 in A549 and H460 cells. Furthermore, arjunic acid upregulated the expression of endoplasmic reticulum (ER) stress proteins such as IRE1 α, ATF4, p-eIF2α, and C/EBP homologous protein (CHOP) in A549 and H460 cells. Conversely, CHOP depletion attenuated the increase of sub-G1 population by arjunic acid, and also JNK inhibitor SP600125 blocked the cytotoxicity and upregulation of IRE1 α and CHOP induced by arjunic acid in A549 and H460 cells. Overall, our findings suggest that arju...Continue Reading

References

May 26, 2001·The Journal of Clinical Investigation·D Ron
Aug 18, 2004·Molecular and Cellular Biology·Jaime D BlaisJohn C Bell
Nov 17, 2007·Planta medica·Mohit SaxenaS P Khanuja
Feb 29, 2008·The American Journal of Chinese Medicine·Fang-Yun SunGuan-Hua Du
May 3, 2008·Mayo Clinic Proceedings·Julian R MolinaAlex A Adjei
Jan 19, 2010·Biochimica Et Biophysica Acta·Eun Kyung Kim, Eui-Ju Choi
Jul 19, 2011·Chemistry & Biodiversity·Beaudelaire Kemvoufo PonouLéon Azefack Tapondjou
Mar 21, 2012·The Journal of Experimental Medicine·Seung-Ah YooWan-Uk Kim
Apr 10, 2013·Journal of Hepatology·Catherine BrennerGuido Kroemer
Aug 21, 2013·Nature Reviews. Immunology·J Simon C Arthur, Steven C Ley
Aug 31, 2013·Nature Reviews. Drug Discovery·Claudio HetzHeather P Harding
Oct 12, 2013·Protein Science : a Publication of the Protein Society·Wolfgang Peti, Rebecca Page
Feb 22, 2014·AJR. American Journal of Roentgenology·Jeffrey P Kanne
Aug 15, 2014·Frontiers in Cellular Neuroscience·Namrata ChaudhariPalaniyandi Ravanan
Feb 19, 2015·Archives of Toxicology·Eun Kyung Kim, Eui-Ju Choi
Apr 19, 2015·BMC Complementary and Alternative Medicine·Aungkana KrajarngRamida Watanapokasin
Apr 29, 2015·Journal of Inflammation·Huibin HuangSarah X Zhang
May 16, 2015·Cancer Discovery·Eric ChevetAfshin Samali
May 20, 2015·Seminars in Cancer Biology·Dadi JiangAlbert C Koong
Jul 3, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·David P CarboneLuis Paz-Ares

❮ Previous
Next ❯

Citations

Jul 10, 2019·Frontiers in Pharmacology·Li LinQiuyue Wang
May 10, 2019·Naunyn-Schmiedeberg's Archives of Pharmacology·T Mohan ManuFarhath Khanum
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jiang WanJin-Feng Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis